How to Stop or Reverse Skin Aging (2026)

AustraliaLongevity · July 22, 2026, 12:02am

Currently experimenting with a home made melatonin face serum.

Why I like it more than retinoids:
Retinoids on paper are great. In practice I find they irritate me to no end. I’m not sure I’ll ever be able to use them on my face which is unfortunate. No matter how strict I am with sunscreen I always end up with red skin. I’m just too prone to it.

But I am a very enthusiastic person. I do think I tend to use a new thing too much. In the future I will try strictly experimenting with a low % adapalene 2-3x a week.

Melatonin on the other hand no only can be put on in the morning in the sun, it shows photoprotective effects in studies. This is a huge bonus. It is currently my only major skin active AM and PM.

My home made recipe is very cheap as well, not that retinoids are expensive if you get them from Indian pharmacies.

My recipe:

I put pure melatonin powder in a glass jar with propylene glycol. I submerged the bottom part of the jar in warm/hot water and stirred continually to dissolve it into solution. Once dissolved I would add more and continue this process until it stopped fully dissolving. Once I reached this stage I then took my usual moisturizer, Cerave PM, and started adding this in and stirring it to incorporate.

In hindsight I think having the moisturizer in a container and slowly adding the melatonin solution and mixing it in would be a better method as the way I did it resulted in the moisturizer clumping up and being hard to fully mix in. Eventually it did mix in, I just resubmerged the bottom of the jar in warm/hot water and stirred vigorously.

I find this melatonin serum to be perhaps a little too concentrated. If I put it on and don’t put moisturizer on top right away it feels like it burns a bit. But this might be the propylene glycol.

Things to consider:

From what I can see you need to keep this in the refrigerator. This is the only flaw for me. I’d rather keep it in the bathroom with my moisturizer for more streamlined use. Perhaps decanting a small amount into a small amber glass jar is viable.
If you want to get a specific melatonin % in your serum you will need strict measurement. I’m not sure what the saturation point of melatonin in propylene glycol is, but 12.5% in studies was what was needed for maximum photoprotection. Lower % is useful for other anti-aging effects.
My thought was to just get the highest % and get all of the benefits, especially since bulk melatonin powder isn’t really that expensive. Especially compared to buying premade melatonin serums.

I had Claude AI summarize all of the major studies on topical melatonin:

“Clinical Studies Using Topical Melatonin” (2024) — reviews 18 clinical trials on topical melatonin for photoprotection, anti-aging, and hair growth (PubMed search through Dec 2023).

“Unveiling the Anti-Aging Potential of Topical Melatonin: A Systematic Review” (2026) — broader pooled analysis. Topical melatonin (alone or combined) associated with skin hydration up to +59.5%, firmness up to +30%, wrinkle depth reduction −11% to −31%. Mechanistic findings: downregulated mTORC1, decreased MMP-1, increased collagen 17A1, fibrillin-1, and mitochondrial markers (TFAM, MTCO-1, VDAC).

UV protection / erythema

Bangha et al., dose-response (1996) — 20 volunteers, UVB exposure on lower back, 0.05%/0.1%/0.5% melatonin gel vs. carrier alone. Clear dose-response; 0.5% performed best, significant at 8h post-irradiation. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study - PubMed
Bangha et al., timing study (1997) — melatonin gel applied 15 min before vs. 30/240 min after UV exposure. Pre-exposure application almost completely suppressed erythema; post-exposure application showed no protective effect. This is the key timing data point. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point - PubMed
Dreher, Gabard, Schwindt & Maibach (1998), British Journal of Dermatology — melatonin tested alone and combined with vitamin C/E, applied 30 min pre-UV, 12 subjects (Fitzpatrick II/III). Modest protective effect from vitamins, assessed via chromametry, dermal blood flow, TEWL, and capacitance. https://academic.oup.com/bjd/article-abstract/139/2/332/6683592
Systematic review (2017) — confirms the pattern across the pre-exposure UV literature: protective effect only when applied before exposure, most pronounced in “strong reactor” subgroups. Melatonin for prevention of erythema and oxidative stress in response to ultraviolet radiation - PubMed

Radiation dermatitis (cancer patients)

Ben-David, Elkayam, Gelernter & Pfeffer (2016), Israel Medical Association Journal — 47 women post-lumpectomy, randomized to melatonin emulsion (26) or placebo (21), twice daily during whole-breast radiotherapy. Dermatitis occurred in 59% of the melatonin group vs. 90% of placebo. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial - PubMed
Zetner et al. (2023), Journal of Pineal Research — MELADERM trial — a larger, more rigorous double-blind RCT (48 evaluable patients, 25mg/g melatonin + DMSO cream) designed specifically to confirm the 2016 result. Primary outcomes showed no significant difference on RTOG dermatitis scores (p=0.441) or photographic erythema analysis (p=0.890) at the 2-week primary endpoint. https://onlinelibrary.wiley.com/doi/10.1111/jpi.12873

Worth flagging in your post: this is a case where the positive finding didn’t replicate in a better-powered follow-up. Good instinct to know both sides here rather than just citing the 2016 result.

Anti-aging / wrinkles

Morganti et al. (combined oral + topical melatonin, vitamin E, beta-glucan) — showed benefit at a very low topical concentration (0.0002%), which the review authors flag as notable given how low that dose is relative to other trials.
Sagan et al. — a higher topical concentration (0.012% alone, no added actives) was found less effective than oral melatonin (2.5mg/day) — the opposite pattern from Morganti, suggesting the co-actives (not melatonin alone) may be doing a lot of the work in these combination formulas.
Melatosphere™ trial (2018), Cosmetics — open, evaluator-blinded, 2-month trial using a lipid-based delivery system for melatonin. 3D imaging (ANTERA 3D) showed −31% coarse wrinkle volume, −18% fine wrinkle volume, −17% melanin content. No placebo arm. https://www.mdpi.com/2079-9284/5/4/60
“In & Out” randomized trial (2024/2025) — compared topical-only vs. topical+oral melatonin (with hyaluronic acid and apigenin) over 84 days. Combined regimen beat topical alone: hydration +23.6% vs +18.3%, wrinkle depth −18.5% vs −9.4% (p<0.05). Lipidomic analysis showed increased ceramides and triglycerides, relevant to barrier function. Lipidomic and Instrumental Evaluation of a Melatonin-Based In & Out Strategy Versus Topical Treatment in Skin Aging: A Randomized Prospective Trial - PMC and https://www.mdpi.com/2310-2861/11/11/860

Mechanism (relevant to formulation logic)

Across the review literature, melatonin’s proposed skin mechanisms are: direct free-radical scavenging, upregulation of endogenous antioxidant enzymes (SOD, glutathione peroxidase), immune modulation relevant to inflammation/dermatitis, mitophagy activation supporting mitochondrial turnover, and downregulation of mTORC1/MMP-1 with upregulation of collagen-supportive markers.

What this means for concentration/formulation choices

Pulling from the review’s concentration data across studies: 0.01% has established human skin penetration data; 0.1% has the clearest direct anti-aging trial data; photoprotection studies span 0.5% up to 12.5%; and 2.5% has the strongest overall clinical evidence base. Combination formulas (with vitamin E, beta-glucan, hyaluronic acid, or apigenin) consistently outperform melatonin alone in the anti-aging trials, so if your serum includes complementary actives, that’s consistent with where the strongest data sits.

RapAdmin · August 5, 2026, 5:50pm

Homemade GHK-Cu serum with a splash of Snap-8 for those fine lines. All for a fraction of the cost of buying a commercial product with less potency.

Want instructions and required supplies?

Sources:

Examples of Powder Sources (amazon.com):

Amazon search on “GHK-CU powder”

https://www.amazon.com/s?k=GHK-Cu+RAW+powder&crid=J9HTAVZY5GDD&sprefix=ghk-cu+raw+powder%2Caps%2C214&ref=nb_sb_noss_1

Beth · August 5, 2026, 7:09pm

FWIW, Fable also told me not to make my own GHK CU serum and that The Ordinary serum everyone uses is the wrong vehicle, just as Bijan said.

I didn’t ask why and I still haven’t tried it.

RapAdmin · August 5, 2026, 9:12pm

From today’s Washington Post:

The new frontier of antiaging? Hands.

Some notice their hands are aging more rapidly than their face, and the beauty industry is touting a solution.

When Sharlene Velazquez bought a new car, her hands sat a little higher on the wheel than they usually did. Every day while driving to work or running errands, this new view of her hands upset her.

Velazquez saw volume loss in her hands. Her skin was starting to thin and wrinkles appeared slowly; she wanted to do something about it.

“My hands weren’t looking the same. My hands were not matching my face*,”* she said.

She was one of many women seeking hand rejuvenation treatments to make them look fuller and younger.

Velazquez, a registered nurse who owns a medical aesthetic practice in California, says hands can be a touchy topic of conversation. Hands can show age quickly because they are exposed to so much, including sunshine, water and everything people touch throughout the day. As people age, their skin gets thinner, revealing bone structure and wrinkles; they can even develop sunspots or hyperpigmentation around the knuckles.

But her clients don’t usually come in asking for hand treatments. Instead, it’s almost a ripple effect caused by the new standard of beauty for aging women.

It starts with Botox and filler on the face, something that is completely normalized today. Studies have shown a 4 percent increase in neuromodulator injections (like Botox) within one year, according to a 2024 report from the American Society of Plastic Surgeons.

Many women notice their face no longer matches their neck and chest, and once they fix that inconsistency, they look to other places to close the gaps created by aging. That’s where hand treatments come in.

“It’s per person, per goal because everybody is so different. It’s typically like a combination [of treatments]. Mostly women come in because of volume loss,” Velazquez said.

Skin boosters, calcium-based filler and microneedling are just a few treatments people seek.

Ewoma Ukeleghe, a cosmetic and medical doctor, says skin boosters, such as hyaluronic acid, give instant results by restoring volume lost in the skin.

“Skin boosters are a real metaphorical gateway drug to hand rejuvenation. You’re piercing the skin, which is intense. However, you get that instant payback of plump, soft, hydrated-looking skin,” Ukeleghe said.

Full story: The new frontier of antiaging? Hands. (Washington Post)

RapAdmin · August 8, 2026, 6:33am

Do Copper Peptides Really Work? Dermatologist Reviews the Science

I. Executive Summary

This video provides an evidence-based dermatological analysis of topical copper peptides, focusing on the formulation, clinical efficacy, and sensory performance of Remedy Copper Peptide Complex Advanced Firming Serum ($29.99/1 oz) relative to established cosmeceutical options like The Ordinary Multi-Peptide + Copper Peptides 1% Serum ($32/1 oz). The central thesis highlights that while copper tripeptide-1 (GHK-Cu) possesses valid biological mechanisms—including dermal fibroblast stimulation, extracellular matrix (ECM) upregulation (collagen, elastin, glycosaminoglycans), and suppression of pro-inflammatory cytokines—the commercial marketing vastly exaggerates its real-world clinical magnitude. Endogenous GHK-Cu levels decline with human aging, but topical application yields modest cosmetic improvements in skin elasticity and wrinkle depth rather than true systemic anti-aging or profound structural rejuvenation. Furthermore, clinical trials demonstrating topical efficacy are limited by short 12-week evaluation windows, small sample cohorts, manufacturer funding, and multi-ingredient complex formulations that obscure the isolated contribution of GHK-Cu.

Formulation analysis of the Remedy serum reveals a fragrance-free vehicle containing verified humectants (glycerin, polyglutamic acid, hyaluronic acid), barrier-supportive extremolytes (ectoin), soothing agents (allantoin, Centella asiatica, turmeric), and secondary peptides (Palmitoyl Tripeptide-5, Acetyl Hexapeptide-8). However, real-world dermatological testing exposed a functional vehicle flaw: despite its hydrating ingredient profile, the product produced an immediate drying, tight, squeaky-clean film on the skin upon drying. This required heavy emollient intervention and failed to match the sensory hydration provided by competitor formulations.

From a cosmeceutical protocol perspective, popular social media myths regarding GHK-Cu—such as catastrophic oxidation when layered with L-ascorbic acid, structural incompatibility with retinoids/AHAs, or skin “purging” (“copper uglies”)—are dismissed as unsupported by cosmetic chemistry. Topically applied copper peptides remain non-exfoliating, highly tolerated secondary actives. Conversely, the trend of systemic or injectable GHK-Cu for longevity represents an unvalidated, high-risk practice lacking human safety data and flagged by regulatory agencies for immunogenic risks. Ultimately, topical copper peptides offer minor, supplementary cosmetic value that cannot replace foundational dermatological pillars: daily broad-spectrum sunscreen, topical retinoids, and basic barrier-repair moisturizers.

II. Insight Bullets

Endogenous GHK-Cu Physiology: Glycyl-L-histidyl-L-lysine (GHK) is a naturally occurring human tripeptide with high binding affinity for Cu(II), present in plasma at ~200 ng/mL at age 20 and declining to ~80 ng/mL by age 60 (Pickart et al., 2018).
Unproven Causality of Serum Decline: The age-dependent decrease in systemic circulating GHK-Cu lacks established clinical causality with specific degenerative human pathologies (Pickart et al., 2018).
Fibroblast Activation & ECM Biosynthesis: Preclinical evidence establishes that GHK-Cu stimulates dermal fibroblasts to increase synthesis of type I collagen, elastin, and glycosaminoglycans (GAGs) (Dou et al., 2020).
Pro-Angiogenic Growth Factor Induction: In vitro models show GHK-Cu upregulates basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), supporting microvascular capillary formation during tissue repair (Dou et al., 2020).
Anti-Inflammatory & Antioxidant Activity: GHK-Cu suppresses reactive oxygen species (ROS) and downregulates pro-inflammatory cytokines, specifically tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) (Dou et al., 2020).
Preclinical Translational Gap: Extrapolating wound-healing data from rodent models and cell cultures directly to anti-aging efficacy in healthy human skin represents a significant translational leap.
Human Clinical Trial Efficacy: Double-blind, placebo-controlled 12-week human trials demonstrate statistically significant improvements in skin firmness, elasticity, and wrinkle depth from topical GHK-Cu (Badenhorst et al., 2025).
Methodological Limitations of Clinical Data: Published clinical evidence for copper peptides is constrained by short study durations (12 weeks), small trial cohorts, industry funding bias, and combination formulations that hide individual peptide contribution.
Market Price Benchmarking: Remedy Copper Peptide Complex ($29.99/1 oz) is priced comparably to main market competitors such as The Ordinary Multi-Peptide + Copper Peptides 1% ($32/1 oz).
Glycerin Mechanics in Line Smoothing: High concentrations of glycerin diminish transepidermal water loss (TEWL) and temporarily swell the stratum corneum, creating optical scattering that rapidly smooths superficial fine lines.
Polyglutamic Acid Film Formation: Polyglutamic acid functions as a high-molecular-weight humectant that forms a thin moisture-retaining film over the epidermis to complement lower-molecular-weight hyaluronic acid.
Hydration Dependency of Epidermal Desquamation: Adequate water content in the stratum corneum is required for proper activity of desquamative enzymes responsible for smooth skin texture and barrier turnover.
Ectoin as an Osmoprotective Extremolyte: Ectoin stabilizes cellular membranes and proteins, acts as an antioxidant, and attenuates UV- and stress-induced epidermal damage (Wang et al., 2025).
Allantoin Anti-Irritant Mechanism: Allantoin combines soothing anti-inflammatory properties with mild keratolytic activity to soften rough, hyperkeratotic skin.
Botanical Antioxidant Support: Extracts of Centella asiatica (asiaticoside/madecassoside) and turmeric (Curcuma longa) provide complementary polyphenolic antioxidants and wound-healing support.
Palmitoyl Tripeptide-5 Mechanism: Palmitoyl Tripeptide-5 mimics the thrombospondin-1 (TSP-1) sequence to activate latent transforming growth factor-beta (TGF-beta), inducing downstream collagen gene expression (Gorouhi et al., 2009).
Argireline Penetration Limitations: Acetyl Hexapeptide-8 (Argireline) competitively inhibits SNARE complex assembly in vitro, but topical formulations fail to penetrate to the deep neuromuscular junction in vivo to replicate botulinum toxin activity (IJMS, 2025).
Superoxide Dismutase (SOD) Formulation Instability: Enzymatic antioxidants like SOD require strict formulation stability and specific catalytic environments to maintain bioactivity in topical cosmeceuticals (PMC7235401).
Debunking L-Ascorbic Acid Incompatibility: Cosmetic chemistry consensus indicates that layering topical GHK-Cu alongside L-ascorbic acid does not cause significant peptide destabilization or oxidative failure in practical daily application.
Retinoid & AHA Layering Compatibility: Topical copper peptides do not induce chemical degradation when paired with retinoids or alpha hydroxy acids, provided individual skin barrier tolerance is maintained.
Refutation of “Copper Uglies” / Purging: GHK-Cu does not increase cell turnover or induce follicular acne purging; reported reactions stem from vehicle intolerance or pre-existing barrier impairment.
Vehicle Physics vs. Ingredient Lists: Remedy Serum produced an immediate dry, tight, squeaky-clean film post-application, demonstrating that formula aesthetics and vehicle interaction can override a logically designed ingredient list.
Proper Product Layering Order: Water-based peptide serums should be applied after cleansing and thin toners, but prior to heavy occlusive moisturizers, prescription retinoids, and daily broad-spectrum sunscreen.
Economic Prioritization in Longevity Skincare: Peripheral cosmeceutical peptides ($30–$32/oz) offer minor incremental benefits and should only be considered after securing essential core pillars (sunscreen, retinoids, humectants).
Injectable GHK-Cu Safety Hazards: Systemic/injectable GHK-Cu lacks rigorous human safety profiling and has been categorized by the US FDA as a bulk drug substance presenting significant safety risks, including immunogenicity and peptide aggregation (FDA, 2023).

IV. Actionable Protocol (Prioritized)

High Confidence Tier (Level A/B Evidence)

Daily Broad-Spectrum Photoprotection: Apply broad-spectrum SPF 30+ sunscreen daily to prevent UV-induced reactive oxygen species, matrix metalloproteinase (MMP) activation, and collagen/elastin degradation (Level A).
Topical Retinoid Therapy: Utilize prescription tretinoin or over-the-counter retinol/retinaldehyde to accelerate epidermal turnover and stimulate dermal procollagen synthesis (Level A/B).
Multi-Depth Epidermal Hydration: Apply foundational humectants (Glycerin, Hyaluronic Acid) daily to optimize stratum corneum water content, suppress transepidermal water loss (TEWL), and maintain desquamative enzyme kinetics (Level A/B).

Experimental Tier (Level C/D Evidence with High Safety Margins)

Topical GHK-Cu (Copper Tripeptide-1) 1% Serum: Apply 3–5 drops of topical GHK-Cu serum once or twice daily to clean skin prior to heavy creams to support minor improvements in skin elasticity, firmness, and superficial wrinkle depth (Badenhorst et al., 2025) (Level B/C).
Topical Barrier-Supportive Osmoprotectants (Ectoin 0.5–2%): Incorporate ectoin-containing topical formulations to enhance skin barrier resilience, calm neurogenic inflammation, and scavenge environmental ROS (Wang et al., 2025) (Level C/D).
Flexible Actives Layering: Co-apply topical copper peptides with L-ascorbic acid, retinoids, or AHAs in the same or alternating routines (AM/PM), monitoring strictly for personal barrier tolerance rather than theoretical chemical conflicts (Level C/D).

Red Flag Zone (Debunked or Safety Data Absent)

Systemic / Injectable GHK-Cu Administration: Safety Data Absent. Systemic or compounded subcutaneous injections of GHK-Cu carry high immunogenicity risks, potential peptide aggregation, and compounding impurities. Placed on the FDA Category 2 Bulk Drug Substance risk list (FDA, 2023).
Topical Argireline as a “Botox Substitute”: Debunked. Topical Acetyl Hexapeptide-8 cannot achieve sufficient transdermal penetration to reach deep facial neuromuscular junctions; clinical wrinkle reduction is primarily driven by vehicle surface hydration (IJMS, 2025).

qBx123Yk · August 10, 2026, 11:08pm

OK, I have acquired siroskin 0.1%. I think I may use it in my left hand/arm and compare with my right one for any changes. Does anyone have any dosage tips?

AustraliaLongevity · August 10, 2026, 11:48pm

Anyone try straight vitamin E oil? I’ve heard really good things but never bothered since it seemed so basic that I didn’t think it would do much.

I ordered some and will be trying it out.

Still using melatonin face serum I made and will likely continue using this.

RapAdmin · August 11, 2026, 12:02am

You can pull information from the original paper on this topic: Rapamycin May Slow Skin Aging (Drexel U. Study)

RapAdmin · August 11, 2026, 12:34am

Are You Using Copper Peptides WRONG? (Dr. Dray, Dermatologist)

I. Executive Summary

In this clinical guidance, board-certified dermatologist Dr. Dray evaluates the widespread internet myths surrounding topical copper tripeptide-1 (GHK-Cu) and reframing its actual utility in dermatological practice. Social media skincare discourse frequently asserts that copper peptides cannot be co-administered with other potent active ingredients, specifically L-ascorbic acid (vitamin C) and topical retinoids (tretinoin, tazarotene, trifarotene, adapalene, retinol, and retinaldehyde). Proponents of these restrictions claim that copper ions induce rapid oxidation of L-ascorbic acid or chemically degrade retinoids. However, Dr. Dray clarifies that these warnings rely on theoretical chemical incompatibilities in unchelated aqueous solutions that do not reflect finished, stable cosmetic formulations on human skin. In well-formulated GHK-Cu complexes, copper is tightly bound to the tripeptide, preventing free ionic copper from driving oxidation. Provided an individual’s skin barrier tolerates the combined regimen, copper peptides can be safely layered alongside retinoids, L-ascorbic acid, or novel biologics like polydeoxyribonucleotides (PDRN).

Beyond formulation compatibility, Dr. Dray addresses the clinical efficacy of GHK-Cu. While marketing campaigns frequently position copper peptides as a revolutionary anti-aging breakthrough, robust human clinical trial data demonstrating meaningful dermal remodeling, elastin regeneration, or deep wrinkle reduction remains limited. Preclinical literature confirms that GHK-Cu upregulates collagen synthesis, decorin, and tissue inhibitors of metalloproteinases (TIMPs) in vitro and accelerates animal wound repair (Pickart & Margolina, 2018). However, topically applied GHK-Cu in human cosmetic formulations functions primarily as a high-performing humectant. Its main observable effect is enhancing stratum corneum moisture retention, which temporarily plumps the epidermis, smooths surface texture, and reduces superficial fine lines. Consequently, while GHK-Cu is a well-tolerated supportive hydrating agent, its cosmetic outcomes are fundamentally comparable to standard barrier moisturizers rather than potent, structural anti-aging interventions like prescription retinoids or daily broad-spectrum photoprotection.

II. Insight Bullets

Theoretical vs. Clinical Incompatibility: Social media claims that copper peptides chemically degrade L-ascorbic acid or retinoids rely on theoretical aqueous chemistry, not clinical dermatological data.
Chelation Prevents Oxidation: In GHK-Cu, copper is tightly chelated to the glycyl-L-histidyl-L-lysine tripeptide, preventing free copper ions from driving rapid ascorbate oxidation (Pickart et al., 2015).
Cutaneous Tolerance Is Individual: The limiting factor when combining copper peptides with retinoids or acids is individual skin barrier tolerance, not chemical destruction of the molecules.
Retinoid Compatibility: Copper peptides can be safely co-applied with all classes of topical retinoids, including tretinoin, tazarotene, trifarotene, adapalene, retinol, and retinaldehyde.
Vitamin C Co-Application: There is no clinical evidence demonstrating that layering topical GHK-Cu with L-ascorbic acid neutralizes the biological efficacy of either compound on intact human skin.
Biologic Ingredient Co-Application: Copper peptides are fully compatible with emerging topical actives, such as polydeoxyribonucleotide (PDRN) formulations.
Preclinical vs. Clinical Evidence Gap: GHK-Cu displays extensive in vitro and animal wound-healing data, but high-quality, large-scale human randomized controlled trials for anti-aging remain sparse (Pickart & Margolina, 2018).
Endogenous GHK Decline: Endogenous plasma levels of GHK drop from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, correlating with reduced systemic tissue repair capacity (Pickart et al., 2015).
Extracellular Matrix Regulation: In vitro models show GHK-Cu modulates both collagen synthesis and matrix metalloproteinase (MMP) activity, balancing tissue remodeling during wound healing.
Epidermal Moisture Retention: In cosmetic dermatology, the primary functional mechanism of topical GHK-Cu is increasing stratum corneum hydration.
Superficial Wrinkle Plumping: The visual reduction in fine lines achieved by copper peptides is largely secondary to transient epidermal plumping from improved moisture binding.
Equivalence to Barrier Moisturizers: The cosmetic smoothing effect of GHK-Cu serums closely mirrors the physical outcomes produced by standard, well-formulated barrier moisturizers.
Absence of Explosive Sensitization: Layering copper peptides with other actives will not cause acute chemical destruction of the skin barrier, though mild irritant contact dermatitis may occur in sensitive individuals.
Lack of Dermal Rejuvenation Dominance: Copper peptides do not represent a “next frontier” capable of outperforming established dermal remodelers like tretinoin or tazarotene.
Stratum Corneum Penetration Limits: As hydrophilic peptides, topical GHK-Cu face significant penetration barriers across the lipophilic stratum corneum unless paired with specialized delivery vehicles.
Non-Oxidative Fenton Safety: Co-administering topical copper peptides and vitamin C does not generate harmful localized Fenton-reaction hydroxyl radicals under standard cosmetic conditions (PMC9856059).
Absence of Retinoid Inactivation: Copper peptides do not interfere with retinoic acid receptor (RAR) binding or nuclear transcription pathways induced by topical retinoids.
Symptomatic Fine Line Relief: Temporary fine line reduction from GHK-Cu reflects short-term stratum corneum hydration rather than permanent structural elastogenesis.
Skincare Routine Simplification: Eliminating artificial wait times or complex ingredient isolation schedules between copper peptides and other actives improves regimen adherence.
Re-Evaluating Cosmetic Hype: Marketing claims exaggerating copper peptides as gene-resetting anti-aging miracles overstate realistic topical clinical outcomes.

RapAdmin · August 14, 2026, 1:56am

I would like to see the science behind this…

Source: Maryanne Alhallak on X: "Everyone owns skincare products, but nobody knows what's actually working. Today, @theantheaguo and I launch @lumeriaskin (YC S26) to end that. The Lumoscope is a multispectral camera that clips onto your phone and scans your skin at home with the same light used in clinics, so https://t.co/y3lmosk7gK" / X

Website:

RapAdmin · August 25, 2026, 7:24am

The Anti-Aging Routine That Actually Works

I. Executive Summary

The video under review presents a concise, over-the-counter (OTC) evening anti-aging regimen combining a third-generation synthetic retinoid (adapalene 0.1% gel, Differin) with an alpha-hydroxy acid (AHA) humectant/exfoliant formulation (12% ammonium lactate lotion, AmLactin Daily Nourish). The presenter argues that this specific two-agent sequence constitutes an optimal, evidence-based photoprotective and dermal-remodeling protocol for facial rejuvenation that requires zero wait time between topical layers.

From a pharmacological and dermatological standpoint, this protocol leverages two biologically active mechanisms: the nuclear retinoic acid receptor (RAR) modulation induced by adapalene and the corneocyte desquamation and hygroscopic properties of ammonium lactate. Adapalene selectively targets RAR-β and RAR-γ subtypes, accelerating epidermal turnover, downregulating matrix metalloproteinases (MMPs), and stimulating type I and III procollagen synthesis in photoaged dermal fibroblasts. Concurrently, lactic acid acts as a kerato-modulator, cleaving desmosomal junctions within the stratum corneum, enhancing natural moisturizing factor (NMF) synthesis, and upregulating epidermal ceramide production.

However, clinical translation reveals significant caveats unaddressed by the presenter. While prescription-strength adapalene (0.3% gel) demonstrated non-inferiority to tretinoin 0.05% cream for cutaneous photoaging in randomized clinical trials (Bagatin et al., 2018), evidentiary backing for over-the-counter adapalene 0.1% monotherapy in reversing severe photoaging remains modest compared to all-trans retinoic acid (tretinoin). Furthermore, co-administering a high-potency keratolytic agent (12% ammonium lactate, pH 4.5–5.5) simultaneously with a topical retinoid substantially increases transepidermal water loss (TEWL) and irritant contact dermatitis risk, particularly on facial skin where 12% lactic acid formulations are notoriously poorly tolerated compared to body sites. While adapalene exhibits superior chemical stability in acidic vehicles relative to photolabile first-generation retinoids, eliminating a dwell time between application steps enhances immediate percutaneous penetration, driving retinoid dermatitis. Thus, while biologically rational, the protocol presents a high irritancy profile requiring strict stratification by patient barrier integrity.

II. Insight Bullets

Protocol Core: The routine prescribes the sequential application of two active topical agents: over-the-counter adapalene 0.1% gel followed immediately by 12% ammonium lactate lotion.
Timing Protocol: The protocol is strictly nocturnal (PM duo), mitigating theoretical daylight photosensitivity and aligning with circadian epidermal barrier repair cycles.
Substrate Preparation: Application is directed onto freshly cleansed facial skin to maximize active bioavailability and eliminate surface sebum interference.
Hydration Modality: The presenter notes application can occur on dry or damp skin, explicitly conceding that application to damp skin elevates cutaneous irritancy.
Penetration Dynamics: Applying lipophilic retinoids to damp skin accelerates vehicle absorption kinetics via transient increases in stratum corneum permeability.
Periorbital Exclusion: The periorbital zone and upper/lower eyelids are strictly contraindicated due to thin stratum corneum architecture and heightened susceptibility to blepharitis and retinoid-induced meibomian gland dysfunction.
Zero Latency Interlayering: The protocol mandates immediate application of the second active layer without an intermediary drying or stabilization period (“no need to wait”).
Chemical Stability Profile: Adapalene possesses high chemical and thermal stability, resisting rapid oxidative degradation when exposed to low-pH formulations unlike all-trans retinoic acid.
Formulation pH Interaction: AmLactin Daily Nourish (neutralized 12% lactic acid/ammonium lactate) operates at an acidic buffer range of approximately pH 4.4 to 5.4.
AHA Concentration: 12% ammonium lactate delivers a high concentration of free acid, functioning primarily as a chemical exfoliant rather than a purely passive humectant.
Retinoid Receptor Target: Adapalene displays selective high-affinity binding to retinoic acid receptors beta and gamma (RAR-β, RAR-γ), bypassing cytosolic retinoic acid-binding proteins (CRABP).
Acne to Photoaging Translation: Adapalene 0.1% was FDA-cleared for acne vulgaris; its anti-aging deployment at 0.1% represents off-label, translationally derived usage.
Off-Label Efficacy Gap: The primary randomized controlled trial confirming adapalene’s non-inferiority to tretinoin for photoaging evaluated the 0.3% formulation, not the OTC 0.1% concentration shown.
Corneocyte Cohesion Disruption: Lactic acid destabilizes ionic bridges in desmosomal cadherins (desmoglein-1), accelerating corneodesmolysis and stratum corneum thinning.
Dermal Remodeling: Retinoid-activated RAR complexes stimulate dermal fibroblasts to synthesize type I and type III procollagen while suppressing collagenase synthesis.
Epidermal Hydration Augmentation: Lactic acid serves as an endogenous component of natural moisturizing factor (NMF), boosting cutaneous water-binding capacity.
Ceramide Biosynthesis: Exogenous L-lactate stimulates ceramide production in human keratinocytes, offering a theoretical compensatory mechanism for barrier compromise.
Additive Irritation Risk: Concurrently layering an AHA and a retinoid drastically increases erythema, peeling, stinging, and micro-fissuring during the retinization window.
Facial vs. Body Formulation: 12% ammonium lactate is clinically indicated for body xerosis and ichthyosis vulgaris; facial application frequently elicits contact stinging.
Lack of Occlusive Buffer: The protocol applies no neutral lipid physiological buffer (ceramides, cholesterol, free fatty acids) prior to active agent administration.
No-Wait Penetration Flux: Eliminating an inter-application latency period creates an emulsion on the stratum corneum that can disrupt uniform vehicle delivery.
Sebosuppression Synergy: Both adapalene and alpha-hydroxy acids modulate follicular keratinization, effectively preventing microcomedone formation while clearing photo-damaged keratinocytes.
UV Sensitization: AHA application causes stratum corneum thinning, which acutely increases baseline erythemal sensitivity to ultraviolet radiation.
Photocarcinogenicity Warnings: Prescribing information for 12% ammonium lactate mandates strict daily photoprotection due to enhanced susceptibility to solar radiation.
Retinoid Tolerance Curve: Adapalene’s rigid naphthoic acid backbone confers higher baseline cutaneous tolerability than equivalent molar concentrations of all-trans retinoic acid.
Skin Barrier Disruption: Simultaneous chemical peeling and nuclear receptor stimulation risk inducing acute barrier failure in Fitzpatrick skin types with underlying rosacea or eczema.
Pigmentary Modulation: The combination targets lentigines via accelerated melanin dispersion (AHA) and direct tyrosinase pathway interference (retinoid).
Neck Application Vulnerability: Extending 12% lactic acid and adapalene down the anterior neck risks severe contact dermatitis due to lower pilosebaceous unit density and thinner dermis.
Absence of Titration Guidance: The video fails to specify frequency titration (e.g., bi-weekly initiation) to induce metabolic retinization safely.
Absence of Photoprotection Context: The short omits morning broad-spectrum SPF mandates, a critical clinical safety prerequisite for any evening keratolytic regimen.

III. Adversarial Claims & Evidence Table

Claim from Video	Speaker’s Evidence	Scientific Reality (Current Data)	Evidence Grade	Verdict
1. Adapalene + Ammonium Lactate is the “Ultimate Anti-Aging PM Duo”	None provided (Implicit expert opinion).	Adapalene 0.3% exhibits non-inferiority to tretinoin 0.05% for photoaging (Bagatin et al., 2018), and AHAs stimulate epidermal renewal (Stiller et al., 1996). However, direct randomized clinical trials evaluating this specific simultaneous stack against standard tretinoin monotherapy are absent.	Level B (for individual agents); Level E (for simultaneous co-application)	Plausible
2. OTC Adapalene 0.1% provides robust anti-aging efficacy	None cited.	Adapalene 0.1% improves histological and clinical markers of photoaging, but higher concentration (0.3%) or tretinoin (0.05%) yields superior procollagen induction and deep wrinkle reduction (Herane et al., 2012).	Level B	Strong Support
3. Face can be wet or damp during application	Anecdotal remark acknowledging it is “more irritating.”	Water enhances stratum corneum hydration and percutaneous flux, accelerating drug absorption and lowering the threshold for acute retinoid and acid-induced irritant contact dermatitis (DailyMed Ammonium Lactate Label). Damp application without buffering is contraindicated for non-acclimated patients.	Level C	Safety Warning
4. Eyelid application must be avoided	Stated as “poorly tolerated by most.”	Supported by clinical data. Periorbital stratum corneum is significantly thinner (<10 layers), predisposing to trans-epidermal penetration, blepharitis, and retinoid-induced meibomian gland dysfunction.	Level A	Strong Support
5. No waiting time needed between applying Adapalene and 12% Ammonium Lactate	Stated directly: “No, you don’t need to wait.”	Adapalene remains chemically stable across acidic pH values (pH 4–7). However, immediately layering 12% lactic acid increases percutaneous penetration and cutaneous irritation due to instantaneous barrier acid-loading without structural stabilization (Rusu et al., 2020).	Level C	Plausible(Pharmacologically compatible, but dermatologically irritating)

IV. Actionable Protocol (Prioritized)

1. High-Confidence Tier (Level A/B Evidence)

Retinoid Monotherapy for Dermal Remodeling: Utilize adapalene 0.1%–0.3% once daily at night. Apply a pea-sized aliquot to fully dried facial skin 20–30 minutes post-cleansing to minimize rapid percutaneous flux.
Broad-Spectrum Photoprotection: Apply a high-SPF (≥30–50), broad-spectrum UVA/UVB sunscreen daily every morning. Retinoids and AHAs thin the stratum corneum, increasing erythema susceptibility and baseline photocarcinogenicity risk under UV load.
Periorbital and Mucosal Safeguarding: Keep all topical retinoids and alpha-hydroxy acids at least 1 cm away from the orbital rim, lateral canthi, and vermilion border.

2. Experimental Tier (Level C/D Evidence with High Safety Margins)

Alternating Night (Contact Cycling) Strategy: Rather than simultaneous single-session layering, alternate active agents on separate evenings (e.g., Adapalene on Monday/Wednesday/Friday; Ammonium Lactate on Tuesday/Saturday). This maintains dermal collagen synthesis while permitting barrier recovery.
Physiological Lipid Buffering: Apply a ceramide-, fatty acid-, and cholesterol-rich physiological moisturizer priorto or blended with active compounds (the “sandwich method”) to preserve stratum corneum lipid bilayers without blunting nuclear transcription.

3. Red Flag Zone (Safety Data Absent / High Irritancy Profile)

Unbuffered Co-application to Damp Facial Skin: Layering 12% free acid (ammonium lactate) directly over adapalene on wet or compromised facial skin leads to acute barrier breakdown, severe transepidermal water loss, and chronic neurosensory burning.
Application on Actively Inflamed or Rosacea-Prone Dermis: High-strength ammonium lactate (12%) is designed primarily for thick-skin xerosis/ichthyosis. Using it on thin, reactive facial skin with compromised vascular tone carries a high risk of long-term barrier insult.